Zimmer Biomet wins expanded FDA nod for shoulder systems

Zimmer Biomet (NYSE:ZBH) announced that it received FDA 510(k) clearance for a line extension to its existing Identity and Comprehensive shoulder system

The clearance expands the existing capabilities for the Identity shoulder system and Comprehensive reverse shoulder systems with additional implant sizes and matching surgical tools. It aims to enable surgeons to treat a wider range of patient statures.

Identity, a modular shoulder replacement system, supports anatomic, reverse and revision total shoulder arthroplasty. The company designed it to enable surgeons to dynamically adapt their procedure to the specific needs of the patient. Identity stems feature proximal anatomic contours and a progressive, flared geometry to complement the natural humeral anatomy.

Sign up for Blog Updates